Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Noriyuki Kasahara

University of Miami School of Medicine, Department: Anatomy/cell Biology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Tocagen, Inc

Disclosed Value
Listed Reason
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)

Dr. Kasahara is an inventor of intellectual property (IP) used in the Study, and is an equity holder in Tocagen, a company that has licensed the IP. A Material Transfer Agreement (MTA) has been executed for Tocagen and Dr. Kasahara, allowing for the use of Tocagen vectors in the Studies.

Listed Research Project
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer

Patients with advanced ovarian cancer have few effective treatment options, and we seek to address this unmet medical need. We will develop new versions of an engineered virus that spreads through tumors and delivers therapeutic genes to kill cancer cells and blocks their ability to suppress the immune system, and will evaluate different routes of administration in metastatic ovarian cancer models. A previous version of our virus has entered late-phase clinical trials in a different type of cancer, so if successful, our results could be rapidly translated into the clinic for recurrent ovarian cancer, as well as for other systemic cancers.

Filed on March 02, 2018.

Tell us what you know about Noriyuki Kasahara's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page